Prespecified secondary analysis of DANFLU-2 (332,438 older adults; 46,788 with CKD): high- vs standard-dose influenza vaccine relative effectiveness against influenza or pneumonia hospitalisation was 16.9% with CKD vs 0.6% without (P interaction=0.046).
Secondary analysisn = 332,438
Bartholdy et al. High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: The DANFLU-2 Trial Subgroup Analysis